questionsmedicales.fr
Actions chimiques et utilisations
Utilisations spécialisées de produits chimiques
Produits chimiques de laboratoire
Sondes moléculaires
Sondes d'acide nucléique
Sondes d'acide nucléique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sondes d'acide nucléique : Questions médicales les plus fréquentes",
"headline": "Sondes d'acide nucléique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sondes d'acide nucléique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-17",
"dateModified": "2025-05-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sondes d'acide nucléique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sondes moléculaires",
"url": "https://questionsmedicales.fr/mesh/D015335",
"about": {
"@type": "MedicalCondition",
"name": "Sondes moléculaires",
"code": {
"@type": "MedicalCode",
"code": "D015335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éléments antisens (génétique)",
"alternateName": "Antisense Elements (Genetics)",
"url": "https://questionsmedicales.fr/mesh/D016375",
"about": {
"@type": "MedicalCondition",
"name": "Éléments antisens (génétique)",
"code": {
"@type": "MedicalCode",
"code": "D016375",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ADN antisens",
"alternateName": "DNA, Antisense",
"url": "https://questionsmedicales.fr/mesh/D016373",
"about": {
"@type": "MedicalCondition",
"name": "ADN antisens",
"code": {
"@type": "MedicalCode",
"code": "D016373",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oligonucléotides antisens",
"alternateName": "Oligonucleotides, Antisense",
"url": "https://questionsmedicales.fr/mesh/D016376",
"about": {
"@type": "MedicalCondition",
"name": "Oligonucléotides antisens",
"code": {
"@type": "MedicalCode",
"code": "D016376",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.640"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Oligodésoxyribonucléotides antisens",
"alternateName": "Oligodeoxyribonucleotides, Antisense",
"url": "https://questionsmedicales.fr/mesh/D020319",
"about": {
"@type": "MedicalCondition",
"name": "Oligodésoxyribonucléotides antisens",
"code": {
"@type": "MedicalCode",
"code": "D020319",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.640.640"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Oligodésoxyribonucléotides antisens",
"alternateName": "Oligodeoxyribonucleotides, Antisense",
"url": "https://questionsmedicales.fr/mesh/D020319",
"about": {
"@type": "MedicalCondition",
"name": "Oligodésoxyribonucléotides antisens",
"code": {
"@type": "MedicalCode",
"code": "D020319",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.640.640"
}
}
},
{
"@type": "MedicalWebPage",
"name": "ARN antisens",
"alternateName": "RNA, Antisense",
"url": "https://questionsmedicales.fr/mesh/D016372",
"about": {
"@type": "MedicalCondition",
"name": "ARN antisens",
"code": {
"@type": "MedicalCode",
"code": "D016372",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.760"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Oligoribonucléotides antisens",
"alternateName": "Oligoribonucleotides, Antisense",
"url": "https://questionsmedicales.fr/mesh/D020320",
"about": {
"@type": "MedicalCondition",
"name": "Oligoribonucléotides antisens",
"code": {
"@type": "MedicalCode",
"code": "D020320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.760.645"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Oligoribonucléotides antisens",
"alternateName": "Oligoribonucleotides, Antisense",
"url": "https://questionsmedicales.fr/mesh/D020320",
"about": {
"@type": "MedicalCondition",
"name": "Oligoribonucléotides antisens",
"code": {
"@type": "MedicalCode",
"code": "D020320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.150.760.645"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sondes d'ADN",
"alternateName": "DNA Probes",
"url": "https://questionsmedicales.fr/mesh/D015342",
"about": {
"@type": "MedicalCondition",
"name": "Sondes d'ADN",
"code": {
"@type": "MedicalCode",
"code": "D015342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.223"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ADN complémentaire",
"alternateName": "DNA, Complementary",
"url": "https://questionsmedicales.fr/mesh/D018076",
"about": {
"@type": "MedicalCondition",
"name": "ADN complémentaire",
"code": {
"@type": "MedicalCode",
"code": "D018076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.223.260"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Amorces ADN",
"alternateName": "DNA Primers",
"url": "https://questionsmedicales.fr/mesh/D017931",
"about": {
"@type": "MedicalCondition",
"name": "Amorces ADN",
"code": {
"@type": "MedicalCode",
"code": "D017931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.223.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sondes d'ADN spécifiques des gènes HLA",
"alternateName": "DNA Probes, HLA",
"url": "https://questionsmedicales.fr/mesh/D015343",
"about": {
"@type": "MedicalCondition",
"name": "Sondes d'ADN spécifiques des gènes HLA",
"code": {
"@type": "MedicalCode",
"code": "D015343",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.223.615"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sondes d'ADN spécifiques du VPH",
"alternateName": "DNA Probes, HPV",
"url": "https://questionsmedicales.fr/mesh/D015344",
"about": {
"@type": "MedicalCondition",
"name": "Sondes d'ADN spécifiques du VPH",
"code": {
"@type": "MedicalCode",
"code": "D015344",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.223.620"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sondes oligonucléotidiques",
"alternateName": "Oligonucleotide Probes",
"url": "https://questionsmedicales.fr/mesh/D015345",
"about": {
"@type": "MedicalCondition",
"name": "Sondes oligonucléotidiques",
"code": {
"@type": "MedicalCode",
"code": "D015345",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sondes d'ARN",
"alternateName": "RNA Probes",
"url": "https://questionsmedicales.fr/mesh/D015347",
"about": {
"@type": "MedicalCondition",
"name": "Sondes d'ARN",
"code": {
"@type": "MedicalCode",
"code": "D015347",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.825"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ARN complémentaire",
"alternateName": "RNA, Complementary",
"url": "https://questionsmedicales.fr/mesh/D018075",
"about": {
"@type": "MedicalCondition",
"name": "ARN complémentaire",
"code": {
"@type": "MedicalCode",
"code": "D018075",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.470.530.600.825.840"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Sondes d'acide nucléique",
"alternateName": "Nucleic Acid Probes",
"code": {
"@type": "MedicalCode",
"code": "D015341",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Na Li",
"url": "https://questionsmedicales.fr/author/Na%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China."
}
},
{
"@type": "Person",
"name": "Ru Sun",
"url": "https://questionsmedicales.fr/author/Ru%20Sun",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China."
}
},
{
"@type": "Person",
"name": "Yu-Jie Xu",
"url": "https://questionsmedicales.fr/author/Yu-Jie%20Xu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, 215123, Suzhou, China."
}
},
{
"@type": "Person",
"name": "Jian-Feng Ge",
"url": "https://questionsmedicales.fr/author/Jian-Feng%20Ge",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China. ge_jianfeng@hotmail.com."
}
},
{
"@type": "Person",
"name": "Bo Tang",
"url": "https://questionsmedicales.fr/author/Bo%20Tang",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39273131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36163292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.disamonth.2022.101468"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2022.09.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35931315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36082759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000000904"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Utilisations spécialisées de produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D020313"
},
{
"@type": "ListItem",
"position": 4,
"name": "Produits chimiques de laboratoire",
"item": "https://questionsmedicales.fr/mesh/D019995"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sondes moléculaires",
"item": "https://questionsmedicales.fr/mesh/D015335"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sondes d'acide nucléique",
"item": "https://questionsmedicales.fr/mesh/D015341"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sondes d'acide nucléique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sondes d'acide nucléique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sondes d'acide nucléique",
"description": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?\nQuelles maladies peuvent être détectées avec des sondes ?\nQuel est le principe de fonctionnement des sondes ?\nLes sondes peuvent-elles détecter des mutations génétiques ?\nQuel type d'échantillons est utilisé pour les sondes ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sondes d'acide nucléique",
"description": "Les sondes d'acide nucléique révèlent-elles des symptômes ?\nPeut-on utiliser des sondes pour surveiller des symptômes ?\nLes sondes peuvent-elles aider à prédire des symptômes ?\nLes sondes sont-elles liées à des symptômes spécifiques ?\nComment les sondes aident-elles à comprendre les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sondes d'acide nucléique",
"description": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?\nComment les sondes aident-elles à la prévention des maladies ?\nPeut-on utiliser des sondes pour la vaccination ?\nLes sondes peuvent-elles détecter des infections précoces ?\nLes sondes sont-elles utilisées dans les programmes de santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sondes d'acide nucléique",
"description": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?\nComment les sondes influencent-elles le choix du traitement ?\nPeut-on développer des traitements basés sur des sondes ?\nLes sondes aident-elles à surveiller l'efficacité des traitements ?\nLes sondes sont-elles utilisées dans les essais cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sondes d'acide nucléique",
"description": "Les sondes d'acide nucléique peuvent-elles causer des complications ?\nQuelles complications peuvent survenir avec des sondes ?\nLes sondes peuvent-elles entraîner des effets secondaires ?\nComment minimiser les complications liées aux sondes ?\nLes sondes sont-elles fiables pour éviter des complications ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sondes d'acide nucléique",
"description": "Quels facteurs de risque sont associés à l'utilisation des sondes ?\nLes sondes sont-elles influencées par des facteurs environnementaux ?\nL'âge est-il un facteur de risque pour l'utilisation des sondes ?\nLes habitudes de vie influencent-elles les résultats des sondes ?\nLes sondes sont-elles affectées par des facteurs génétiques ?",
"url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'identifier des séquences génétiques spécifiques liées à des maladies."
}
},
{
"@type": "Question",
"name": "Quelles maladies peuvent être détectées avec des sondes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour détecter des infections virales, bactériennes et des cancers."
}
},
{
"@type": "Question",
"name": "Quel est le principe de fonctionnement des sondes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se lient spécifiquement à des séquences cibles, permettant leur détection par hybridation."
}
},
{
"@type": "Question",
"name": "Les sondes peuvent-elles détecter des mutations génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines sondes sont conçues pour identifier des mutations spécifiques dans l'ADN."
}
},
{
"@type": "Question",
"name": "Quel type d'échantillons est utilisé pour les sondes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de sang, de tissus ou de fluides corporels peuvent être analysés."
}
},
{
"@type": "Question",
"name": "Les sondes d'acide nucléique révèlent-elles des symptômes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles détectent des séquences génétiques, pas des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des sondes pour surveiller des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en surveillant des biomarqueurs associés à des symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Les sondes peuvent-elles aider à prédire des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent indiquer un risque accru de maladies, mais pas de symptômes immédiats."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles liées à des symptômes spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont liées à des maladies, qui peuvent avoir des symptômes variés."
}
},
{
"@type": "Question",
"name": "Comment les sondes aident-elles à comprendre les symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles aident à identifier les causes génétiques sous-jacentes des symptômes observés."
}
},
{
"@type": "Question",
"name": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en permettant le dépistage précoce de maladies génétiques ou infectieuses."
}
},
{
"@type": "Question",
"name": "Comment les sondes aident-elles à la prévention des maladies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'identifier les individus à risque et de mettre en place des mesures préventives."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des sondes pour la vaccination ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aider à développer des vaccins en identifiant des cibles immunogènes."
}
},
{
"@type": "Question",
"name": "Les sondes peuvent-elles détecter des infections précoces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont efficaces pour détecter des infections à un stade précoce."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles utilisées dans les programmes de santé publique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont intégrées dans des programmes de dépistage et de surveillance épidémiologique."
}
},
{
"@type": "Question",
"name": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas des traitements, mais aident à guider les choix thérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment les sondes influencent-elles le choix du traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient des cibles spécifiques, permettant des thérapies ciblées adaptées."
}
},
{
"@type": "Question",
"name": "Peut-on développer des traitements basés sur des sondes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements peuvent être développés pour cibler des séquences spécifiques."
}
},
{
"@type": "Question",
"name": "Les sondes aident-elles à surveiller l'efficacité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être utilisées pour évaluer la réponse au traitement au niveau moléculaire."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles utilisées dans les essais cliniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour évaluer des biomarqueurs dans les essais cliniques."
}
},
{
"@type": "Question",
"name": "Les sondes d'acide nucléique peuvent-elles causer des complications ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement sûres, mais des erreurs de diagnostic peuvent entraîner des complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des sondes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des faux positifs ou négatifs, affectant le traitement."
}
},
{
"@type": "Question",
"name": "Les sondes peuvent-elles entraîner des effets secondaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles n'ont pas d'effets secondaires directs, mais des erreurs peuvent avoir des conséquences."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications liées aux sondes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En utilisant des protocoles de test rigoureux et en validant les résultats obtenus."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles fiables pour éviter des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement fiables, mais leur précision dépend de la qualité des échantillons."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à l'utilisation des sondes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux de maladies génétiques ou infectieuses."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles influencées par des facteurs environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'exposition à des agents pathogènes peuvent influencer les résultats."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour l'utilisation des sondes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies détectées par sondes sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles les résultats des sondes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme peuvent affecter la santé et les résultats des tests."
}
},
{
"@type": "Question",
"name": "Les sondes sont-elles affectées par des facteurs génétiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des variations génétiques peuvent influencer la sensibilité et la spécificité des sondes."
}
}
]
}
]
}
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
Pulmonary Arterial Hypertension (PAH) is a clinical syndrome consisting of physiologic/hemodynamic criteria that are a consequence of several etiologies. Systemic Sclerosis (SSc), one of the most comm...
Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort....
Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?...
We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II...
In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529...
The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...
Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with...
Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi...
Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0...
Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc...
We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul...
The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv...
SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...
Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare...
A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab...
A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo...
Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....
Systemic sclerosis (SSc), also known as scleroderma, is a chronic autoimmune connective tissue disease and is associated with a significant economic burden resulting from health care utilization costs...